Show simple item record

dc.contributor.authorStarkey, Thomas
dc.contributor.authorTilby, Michael
dc.contributor.authorLee, Lennard Y W
dc.date.accessioned2023-06-01T11:24:39Z
dc.date.available2023-06-01T11:24:39Z
dc.date.issued2023-04-27
dc.identifier.citationJAMA Oncol. 2023 Apr 27. doi: 10.1001/jamaoncol.2023.0778. Online ahead of print.
dc.identifier.eissn2374-2445
dc.identifier.doi10.1001/jamaoncol.2023.0778
dc.identifier.pmid37103944
dc.identifier.urihttp://hdl.handle.net/20.500.14200/884
dc.description.abstractNo abstract available
dc.publisherAmerican Medical Association
dc.relation.urlhttps://jamanetwork.com/journals/jamaoncology/fullarticle/2804131
dc.subjectCommunicable diseases
dc.subjectOncology. Pathology.
dc.titleAssociation of SARS-CoV-2 antibody level with risk of infection or hospitalization-reply
dc.typeArticle
dc.source.journaltitleJAMA Oncology
dc.contributor.trustauthorTilby, Michael


This item appears in the following Collection(s)

Show simple item record